Cannabinoids in PLWHIV on Effective ART

Stopped expiration of study product; end of study product availability

Conditions

• HIV Infections

Interventions

• DRUG: TN-TC11M2 oral capsules (THC 2.5 mg/CBD 2.5 mg)
• DRUG: TN-C200M2 oral capsules (CBD 200 mg)

Sponsor

McGill University Health Centre/Research Institute of the McGill University Health Centre

Collaborators

• [object Object]
• [object Object]
• [object Object]
• [object Object]